Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE:002603)
China · Delayed Price · Currency is CNY 15.26
+0.16 (1.06%)
Jun 9, 2026, 3:04 PM CST
SHE:002603 Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, SHE:002603 stock has a consensus rating of "Strong Buy" and an average price target of ¥20.39. The average 1-year stock price forecast is 33.62% higher than the current stock price, while the lowest is ¥19.38 (+27.00%) and the highest is ¥21.40 (+40.24%).
Price Target: ¥20.39 (+33.62%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SHE:002603 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 3 | 2 | 2 | 2 |
Financial Forecast
Revenue This Year
8.47B
from 7.83B
Increased by 8.19%
Revenue Next Year
9.04B
from 8.47B
Increased by 6.74%
EPS This Year
0.92
from 0.73
Increased by 25.80%
EPS Next Year
1.09
from 0.92
Increased by 18.48%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 8.6B | ||
| Avg | 8.5B | ||
| Low | 8.3B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 10.0% | ||
| Avg | 8.2% | ||
| Low | 6.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 0.92 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 25.8% | ||
| Low | - |